Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
254.81
+6.46 (2.60%)
At close: Nov 9, 2026, 4:00 PM EST
254.88
+0.07 (0.03%)
After-hours: Nov 9, 2026, 6:15 PM EST

Biogen Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
10,2979,8919,6769,83610,17310,982
10,2979,8919,6769,83610,17310,982
Revenue Growth
2.30%2.22%-1.62%-3.32%-7.36%-18.32%
Cost of Revenue
2,4962,0822,1292,5332,2782,110
Gross Profit
7,8027,8087,5477,3027,8958,872
Selling, General & Admin
2,7522,4342,3872,5022,4092,680
Research & Development
1,7291,7291,9052,4422,2292,497
Amortization of Goodwill & Intangibles
609.7507.1386.5240.6246.3252
Other Operating Expenses
290.7290.2254.4218.8-7.47.2
Operating Expenses
5,3824,9614,9335,4034,8775,436
Operating Income
2,4202,8482,6141,8993,0193,436
Interest Expense
-304.9-267.5-250.3-246.9-246.6-250.4
Interest & Investment Income
109.712567.6276.589.311
Earnings From Equity Investments
----2.634.9
Currency Exchange Gain (Loss)
-31-28.6-30.9-50.4-35.5-22.4
Other Non Operating Income (Expenses)
21.529.4-0.22.2-7.1-4
EBT Excluding Unusual Items
2,2162,7062,4001,8802,8213,205
Merger & Restructuring Charges
-859.2-319.2-306.7-271.7-131.1-
Gain (Loss) on Sale of Investments
45-19.7-100.4-291.21,228-824.9
Gain (Loss) on Sale of Assets
--88.6-503.7-
Asset Writedown
-57.3-60.8-60.2--119.6-629.3
Legal Settlements
-166.2-244.4-26.3-3.9-917-
Other Unusual Items
-28.6-33.6-27.7-209.147.5
Pretax Income
445.11,5571,9061,2973,5941,780
Income Tax Expense
97.6263.6273.8135.3632.852.5
Earnings From Continuing Operations
347.51,2931,6321,1622,9621,728
Minority Interest in Earnings
----0.485.3-171.5
Net Income
347.51,2931,6321,1613,0471,556
Net Income to Common
347.51,2931,6321,1613,0471,556
Net Income Growth
-78.40%-20.79%40.57%-61.89%95.80%-61.10%
Shares Outstanding (Basic)
147147146145145149
Shares Outstanding (Diluted)
149147146146146150
Shares Change
1.49%0.82%0.21%-0.27%-2.41%-7.25%
EPS (Basic)
2.368.8311.218.0220.9710.44
EPS (Diluted)
2.348.7911.187.9720.8710.40
EPS Growth
-78.71%-21.38%40.28%-61.81%100.67%-58.06%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
2,0712,0512,7221,2701,1443,382
Free Cash Flow Per Share
13.9313.9418.668.727.8422.61
Gross Margin
75.77%78.95%78.00%74.24%77.61%80.79%
Operating Margin
23.50%28.79%27.02%19.30%29.67%31.29%
Profit Margin
3.38%13.07%16.87%11.80%29.95%14.17%
Free Cash Flow Margin
20.11%20.73%28.13%12.91%11.24%30.80%
EBITDA
3,3023,6283,2872,3943,5373,923
EBITDA Margin
32.07%36.68%33.97%24.34%34.77%35.73%
D&A For EBITDA
881.8779.9673.2494.8518.4487.7
EBIT
2,4202,8482,6141,8993,0193,436
EBIT Margin
23.50%28.79%27.02%19.30%29.67%31.29%
Effective Tax Rate
21.93%16.93%14.37%10.43%17.61%2.95%
Revenue as Reported
10,2979,8919,6769,83610,17310,982
Advertising Expenses
-71.966.871.454.198.7
SEC Filings: 10-K · 10-Q